Dr. Kidd has more than twenty years of molecular and cancer biology laboratory experience focused on oncology and other disciplines. His professional and academic research interests have focused on the biology of neuroendocrine cells and the development of tumor models of the disease. Dr. Kidds publications cover diverse areas including global gene analysis, tissue microarrays, tumor biology, bacterial genetics as well as gastric and pancreatic pathology.
Liquid Biopsies: The Final Frontier for mRNA Assays
Wren Laboratories has identified gene expression signatures for a variety of hematological and solid tumors and, to facilitate clinical application, have developed and validated bloodbased assays based on these unique gene expression signatures. These bloodbased mRNA qPCR assays are used both to confirm the presence of residual disease as well as to monitor disease progression.
Clinical Dx Showcase:
Wren Laboratories is a molecular diagnostics company that develops mRNA-based biomarkers that are assessed with a suite of AI-enabled multianalyte algorithms to identify and characterize a range of cancers and other diseases.
Session Abstract – PMWC 2024 Silicon Valley
The PMWC 2023 Data Applications in Clinical Diagnostics Showcase will provide a 15-minute time slot for selected organizations, including commercial companies, clinical testing labs, and medical research institutions, to present their latest advancements, insights, applications, and technologies to an audience of clinicians, leading investigators, academic institutions, pharma and biotech, investors, and potential clients. We will learn about new technologies and findings that promise expedited, cost-effective, and accurate clinical diagnosis for early disease detection, treatment decisions, and disease prevention.
- Clinical Dx/Oncology (including Liquid Biopsy)
- Clinical Dx/Cardio Vascular
- Clinical Dx/Nerodegenerative